Reshma A. Lalai

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Oral Butyrate Reduces Progression of Kidney Damage in an L-NAME-Induced Diabetic Kidney Disease Mouse Model.

Oral Butyrate Reduces Progression of Kidney Damage in an L-NAME-Induced Diabetic Kidney Disease Mouse Model.

Journal: Diabetes, obesity & metabolism
Published: March 17, 2026

The designer cytokine IC7Fc attenuates atherosclerosis development by targeting hyperlipidemia in mice.

The designer cytokine IC7Fc attenuates atherosclerosis development by targeting hyperlipidemia in mice.

Journal: Science advances
Published: October 24, 2025

A study on the distribution of BK and JC polyomavirus in discarded donor kidneys.

A study on the distribution of BK and JC polyomavirus in discarded donor kidneys.

Journal: Frontiers in transplantation
Published: October 17, 2025

Oral L-NAME supplementation accelerates the progression of kidney disease in diabetic mice.

Oral L-NAME supplementation accelerates the progression of kidney disease in diabetic mice.

Journal: Biochemical and biophysical research communications
Published: June 17, 2025

A rare gain of function variant of hepatic lipase attenuates hypercholesterolaemia and atherosclerosis in mice via an LDL receptor-independent mechanism.

A rare gain of function variant of hepatic lipase attenuates hypercholesterolaemia and atherosclerosis in mice via an LDL receptor-independent mechanism.

Journal: Cardiovascular research
Published: January 16, 2025

Oppositely biased glucagon-like peptide-1 receptor agonism does not differentially affect lipid metabolism in APOE*3-Leiden CETP mice.

Oppositely biased glucagon-like peptide-1 receptor agonism does not differentially affect lipid metabolism in APOE*3-Leiden CETP mice.

Journal: Diabetes, obesity & metabolism
Published: January 16, 2025

Liver-targeted Angptl4 silencing by antisense oligonucleotide treatment attenuates hyperlipidaemia and atherosclerosis development in APOE*3-Leiden.CETP mice.

Liver-targeted Angptl4 silencing by antisense oligonucleotide treatment attenuates hyperlipidaemia and atherosclerosis development in APOE*3-Leiden.CETP mice.

Journal: Cardiovascular research
Published: June 06, 2024

Doublecortin-like knockdown in mice attenuates obesity by stimulating energy expenditure in adipose tissue.

Doublecortin-like knockdown in mice attenuates obesity by stimulating energy expenditure in adipose tissue.

Journal: Scientific reports
Published: April 24, 2024

Time-restricted feeding attenuates hypercholesterolaemia and atherosclerosis development during circadian disturbance in APOE∗3-Leiden.CETP mice.

Time-restricted feeding attenuates hypercholesterolaemia and atherosclerosis development during circadian disturbance in APOE∗3-Leiden.CETP mice.

Journal: EBioMedicine
Published: December 23, 2022

von Willebrand Factor: A Central Regulator of Arteriovenous Fistula Maturation Through Smooth Muscle Cell Proliferation and Outward Remodeling.

von Willebrand Factor: A Central Regulator of Arteriovenous Fistula Maturation Through Smooth Muscle Cell Proliferation and Outward Remodeling.

Journal: Journal of the American Heart Association
Published: August 05, 2022

Aging attenuates diurnal lipid uptake by brown adipose tissue.

Aging attenuates diurnal lipid uptake by brown adipose tissue.

Journal: Aging
Published: June 15, 2022

Gene expression changes in the brain of a Cushing's syndrome mouse model.

Gene expression changes in the brain of a Cushing's syndrome mouse model.

Journal: Journal of neuroendocrinology
Published: August 24, 2021
Showing 1-12 of 20

Last Updated: 09/26/2026